JF
VIR icon

Jump Financial’s Vir Biotechnology VIR Stock Holding History

Jump Financial’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09M Buy
+122,066
New +$973K 0.01% 887
2024
Q4 		– Sell
-32,862
Closed -$246K – 2047
2024
Q3 		$246K Sell
32,862
-82,821
-72% -$719K 0.01% 1385
2024
Q2 		$1.03M Buy
115,683
+35,775
+45% +$343K 0.02% 802
2024
Q1 		$809K Buy
+79,908
New +$814K 0.02% 914
2023
Q4 		– Sell
-50,263
Closed -$471K – 2289
2023
Q3 		$471K Buy
50,263
+36,192
+257% +$516K 0.02% 1051
2023
Q2 		$345K Sell
14,071
-86,382
-86% -$2.17M 0.01% 1237
2023
Q1 		$2.34M Buy
100,453
+60,162
+149% +$1.54M 0.1% 323
2022
Q4 		$1.02M Buy
40,291
+23,491
+140% +$576K 0.05% 474
2022
Q3 		$324K Buy
+16,800
New +$427K 0.01% 1107
2022
Q2 		– Sell
-24,414
Closed -$628K – 2047
2022
Q1 		$628K Buy
+24,414
New +$724K 0.03% 709
2021
Q3 		– Sell
-36,951
Closed -$1.75M – 1528
2021
Q2 		$1.75M Sell
36,951
-349
-0.9% -$15.9K 0.17% 140
2021
Q1 		$1.91M Buy
37,300
+8,351
+29% +$450K 0.18% 109
2020
Q4 		$775K Buy
+28,949
New +$941K 0.13% 228

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Jump Financial's VIR Position: Q1 2026 in Review

Jump Financial opened a new position in Vir Biotechnology (VIR) in Q1 2026: 122,066 shares worth $1.09M. The stake represents 0.01% of the portfolio and ranks #887 among its holdings. This is a return to the name: Jump Financial previously reported a position in VIR as recently as Q3 2024.

Jump Financial first reported a position in VIR in Q4 2020 and has held it in 13 quarters since. The position peaked at $2.34M in Q1 2023. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Jump Financial held 122,066 shares of Vir Biotechnology worth $1.09M as of Q1 2026.
  • Vir Biotechnology was a new Jump Financial position in Q1 2026.
  • Vir Biotechnology made up 0.01% of Jump Financial's portfolio in Q1 2026, its #887 holding.
  • Jump Financial first reported a position in Vir Biotechnology in Q4 2020 and has held it in 13 quarters since.
  • Jump Financial's Vir Biotechnology position peaked at $2.34M in Q1 2023.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.